Abstract:Nanotechnology has been actively employed in the development of drug-delivery systems overcoming the limitations of conventional carriers. In nanomedicine, the ultimate goal is to design and develop a system for the prevention, diagnosis, control, and treatment of debilitating diseases. Nanoparticles can be designed and programmed to have unique physical properties, in order to protect the loaded drug against degradation and/or denaturation by natural processes inside the body, while selectively delivering it to target areas having the desired cells. This effectively minimizes the active pharmaceutical ingredient's (API's) systemic exposure and, consequently, the occurrence of adverse side effects. The enhanced control on the distribution and release of the entrapped drug molecules, through active targeting and controlled-release technology, allows for their increased and accurate cellular uptake. In this review, we summarize the development of nanobased drug-delivery systems, with a focus on smart systems and the necessary characteristics required for the optimal drug nanocarrier. The recently developed class of crystalline porous polymers, covalent organic frameworks (COFs), possesses a unique combination of characteristics including permanent yet tunable discrete pores having high surface areas and large volumes, making them intrinsically designed to accommodate APIs as guest molecules in their highly ordered pores. The extensive synthetic and molecular design flexibility of COFs allows the structural control and tuning of their morphology, regularity, atomic connectivity, and porosity, for this specific application. Through an overview of the recent advancements in the novel application of metal–organic frameworks (MOFs) and COFs as drug nanocarriers, we demonstrate this promising alternative route to effectively increase the drug solubility and enhance the limited loading capacity and release control of nanoparticle systems. Since the first reported COF nanocarriers in 2011 as passive targeting drug-delivery systems, this application of COFs has been slowly gaining traction, with increasingly complex COF nanocarrier drug-delivery systems reported in the past year.

Tailored Drug Delivery Platforms: Stimulus‐Responsive Core‐Shell Structured Nanocarriers

Stimuli-responsive Image-Guided Nanocarriers As Smart Drug Delivery Platforms

Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms

Self-Assembly of Biocompatible Core-Shell Nanocapsules with Tunable Surface Functionality by Microfluidics for Enhanced Drug Delivery

Synthesis of the Core-Shell Structure Materials As the Controlled-Release Drug Carrier

Precise Design Strategies of Nanotechnologies for Controlled Drug Delivery

The Smart Drug Delivery System and Its Clinical Potential

Nanocarriers and Their Loading Strategies

Endogenous Stimuli-responsive Nanocarriers for Drug Delivery

Chemo-drug Controlled-release Strategies of Nanocarrier in the Development of Cancer Therapeutics

Smart drug delivery systems for precise cancer therapy

Harnessing the Power of Stimuli‐Responsive Nanoparticles as an Effective Therapeutic Drug Delivery System

Emerging frontiers in drug release control by core–shell nanofibers: a review

Nanoparticle‐Empowered Core–Shell Microcapsules: From Architecture Design to Fabrication and Functions

Capsules with Responsive Polymeric Shells for Applications Beyond Drug Delivery

Hollow structures as drug carriers: Recognition, response, and release

Evolution of Nanocarrier Drug-Delivery Systems and Recent Advancements in Covalent Organic Framework–Drug Systems

Core–shell SrTiO3:Yb3+,Er3+@mSiO2 nanoparticles for controlled and monitored doxorubicin delivery

A Facile Design of Smart Silica Nanocarriers Via Surface-Initiated RAFT Polymerization As a Dual-Stimuli Drug Release Platform

A Perspective on Magnetic Core-Shell Carriers for Responsive and Targeted Drug Delivery Systems.

Stimuli-Responsive Dendrimers in Drug Delivery